Stock Scorer

EXOSENS (EXENS.PA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in EUR. Every figure as a table ›

Revenue Annual

0 200M 400M 600M FY23: 291.8M FY24: 383.4M FY25: 468.2M FY23 FY24 FY25

Operating Income Annual

0 35M 70M 105M FY23: 48.3M FY24: 76.8M FY25: 102M FY23 FY24 FY25

Net Income Annual

0 15M 30M 45M FY23: 18.4M FY24: 30.7M FY25: 42.7M FY23 FY24 FY25

Operating Cash Flow Annual

0 40M 80M 120M FY23: 50.5M FY24: 98.7M FY25: 107.3M FY23 FY24 FY25

EPS Annual

0.00 0.30 0.60 0.90 FY23: 0.24 FY24: 0.61 FY25: 0.84 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for EXENS.PA: Gross Profit, Cost of Revenue, Free Cash Flow, Shares Outstanding. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.